- Home
- ABEO vs MITT Comparison
ABEO vs MITT Comparison
Compare ABEO & MITT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABEO | MITT |
|---|---|---|
| Founded | 1974 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 281.0M | 287.6M |
| IPO Year | 1980 | 2011 |
Fundamental Metrics
Financial Performance| Metric | ABEO | MITT |
|---|---|---|
| Price | $5.09 | $8.81 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $18.20 | $9.04 |
| AVG Volume (30 Days) | ★ 1.2M | 185.7K |
| Earning Date | 03-19-2026 | 03-02-2026 |
| Dividend Yield | N/A | ★ 10.42% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.29 | 0.94 |
| Revenue | $400,000.00 | ★ $87,678,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,589.77 | $16.68 |
| P/E Ratio | ★ $4.03 | $9.41 |
| Revenue Growth | N/A | ★ 8.59 |
| 52 Week Low | $3.93 | $5.63 |
| 52 Week High | $7.54 | $9.27 |
Technical Indicators
Market Signals| Indicator | ABEO | MITT |
|---|---|---|
| Relative Strength Index (RSI) | 46.51 | 54.15 |
| Support Level | $5.00 | $8.67 |
| Resistance Level | $5.41 | $9.16 |
| Average True Range (ATR) | 0.24 | 0.22 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 14.33 | 54.30 |
Price Performance
Historical ComparisonAbout ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About MITT AG Mortgage Investment Trust Inc.
TPG Mortgage Investment Trust Inc is a real estate investment trust (REIT). It focuses on investing in a diversified risk-adjusted portfolio of residential mortgage-related assets in the U.S. mortgage market. Its objective is to provide attractive risk-adjusted returns to its stockholders over the long term through dividends and capital appreciation.